The prognostic values of cardiac rhythm indicators variability in patients with ischemic heart disease and diabetes mellitus

Abstract

The diabetic cardiomyopathy leads to the premature aging of myocardium, which loses its catecholamine compliance and sensitivity. This condition becomes health dangerous as far as the essential hypertension and coronary heart disease progress. The neuropathic denervation of heart, most of the time partial, impacts on the parasympathetic nervous system and deteriorate the heart functional system and can become a cause of sudden death. In patients with diabetes mellitus, such consequences as specific disturbances of lipid metabolism, triglyceridemia, potentiated chronic hyperglycemia, insulin resistance, essential hypertension, disturbance of coagulation are the issues to be discussed.

Keywords

cardiac rhythm variability / ischemic heart disease / diabetes mellitus

References

[1] Баевский Р.М., Иванов Г.Г., Чирейкин Л.В. и др. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем. Методические рекомендации // Вестн. аритмол. - 2001. - № 24. - С. 65-86.

[2] Парнес Е.Я. Клиническое значение вариабельности сердечного ритма. - М., 2010.

[3] Bigger J.Т., Fleiss J.L., Steinman R.С. et at. Frequency domain measures of heart period variability and mortality after myocardial infarction // Circulation. - 1992. - Vol. 85. - P. 164.

[4] Clarke B.F., Ewing D.J., Campbell I.W. Diabetic autonomic neuropathy // Diabetologia. - 1979. - Vol. 17. - P. 195-212.

[5] Ewing D.J., Borsey D.Q, Bellavere F., Clarke B.F. Cardiac autonomic neuropathy in diabetes: comparison of measure of RR interval variation // Diabetologia. - 1981, - Vol. 21. - P. 18-24.

[6] Grimaldi A., Gonzalez J., Bosquet F., Komajda M. Heart involvement in diabetic patients // Presse Med. - 1990. - Vol. 19, N 11. - P. 519-524.

[7] Heart rate variability. Standarts of measurement, physiologican interpretation and clinic use. Task force of the Europen Society of Cardiology and the North American Society of Pacing and Electrophysiology // Eur. Heart J. - 1996. - Vol. 17. - P. 354-381.

[8] Hussain S., Siddique S., Saboor Q.A. Heart rate variability in early phase of acute myocardial infarction and convalescence // J. Coll. Physicians Surg. Pak. - 2003. - Vol. 13, N 2. - P. 67-69.

[9] Jose A.D., Taylor R.R. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man // J. Clin. Invest. - 1969. - Vol. 48. - P. 2019.

[10] Kleiger R., Bosner M. Correlation of time and freguence domain measures of heart rate variability // Noninvasive Electrocardiology. Clinical Aspects of Holter Monitoring // Eds A. Moss, S. Stem. - Cambridge, 1997. - P. 199-206.

[11] Lakusic N., Milicevic G., Mahovic D. et. al. Assessment of heart rate variability in patients after myocardial infarct // Lijec. Vjesn. - 2001. - Vol. 123, N 5-6. - P. 120-123.

[12] Liao D., Sloan R.P., Cascio W.E. et al. Multiple metabolic syndrome is associated with lower heart rate variability // Diabet. Care. - 1998. - Vol. 21. - P. 2116-2122.

[13] Liu P.Y., Tsai W.С., Lin L.J. et al. Time domain heart rate variability as a predictor of long-term prognosis after acute myocardial infarction // J. Formos. Med. Assoc. - 2003, - Vol. 102, N 7. - P. 474-479.

[14] Lombardi F., Mortara A. Heart rate variability and cardiac failure // Heart. - 1998. - Vol. 80. - P. 213-214.

[15] Lombardi F., Sandrone G., Pempruner S. et al. Heart rate variability as an index of sympatho-vagal interaction after acute myocardial infarction // Am. J. Cardiol. - 1987. - Vol. 60. - P. 1239-1245.

[16] Lucini D., Milani R.V., Costantino G. et al. Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease // Am. Heart J. - 2002. - Vol. 143, N 6, - P. 977-983.

[17] McNally P.G., Lawrence I.G., Panerai R.B. et.al. Sudden death in type 1 diabetes // Diabet. Obes. Metab. - 1999. - Vol. 1, N 3. - P. 151-158.

[18] Priory S.G., Aliot E, Blomstorm-Lundqvist C. et al. Task force on sudden cardiac death of the European Society of Cardiology // Eur. Heart J. - 2001. - Vol. 22. - P. 1374-1450.

[19] Rathmann W., Ziegler D., Jahnke M. et al. Mortality in diabetic patients with cardiovascular autonomic neuropathy // Diabet. Med. - 1993. - Vol. 10, N 9. - P. 820-824.

[20] Singh N. Diabetes, heart rate, and mortality // J. Cardiovasc. Pharmacol. Ther. - 2002. - Vol. 7, N 2. - P. 117-129.

[21] Singh N., Mironov D., Armstrong P.W. et al. Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO EGG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries // Circulation. - 1996. - Vol. 93, N 7. - P. 1388-1395.

[22] Sosnowski M. et al. Age-adjustment of HRV measures and its prognostic value for risk assessment in patients late after myocardial infarction // Int. J. Cardiol. - 2002. - Vol. 86, N 2-3. - P. 249-258.

[23] Stein P.K. Assessing heart rate variability from real-world Holter reports // Card Electrophysiol. Rev. - 2002. - Vol. 6, N 3. - P. 239-244.

[24] Stis A., Stis T. Current clinical applications of heart rate variability // Clin. Cardiol. - 1998. - Vol. 21, N 10. - P. 719-724.

[25] Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiologic interpretation, and clinical use // Circulation. - 1996. - Vol. 93. - P. 1043.

[26] Tsuyi H., Larson M.G., Venditti F.J. et al. Impact of reduced heart rate variability on risk for cardiac events: The Framingham heart study // Circulation. - 1996. - Vol. 94. - P. 2850-2855.

[27] Tsuyi H., Venditti F., Manders E. et al. Reduction heart rate variability and mortalality risk in elderly cohort. The Framingham heart study // Circulation. - 1994. - Vol. 90. - P. 878-883.

[28] Vaage-Nilsen М., Rasmussen V., Jensen G. et al. Recovery of autonomic nervous activity after myocardial infarction demonstrated by short-term measurements of SDNN // Scand. Cardiovasc. J. - 2001. - Vol. 35, N 3. - P. 186-191.

[29] Voile J.C., Fletcher J., Al-Ani M. et al. Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control // Clin. Sci. (Lond.). - 1999. - Vol. 97, N 5. - P. 609-610.

[30] Zbilut J.P., Lawson L. Decreased heart rate variability in significant cardiac events // Crit. Care Med. - 1988. - Vol. 16, N 1. - P. 64-66.

RIGHTS & PERMISSIONS

Eco-Vector